Abstract
To address the causes for obesity in all of China is not feasible in a single article. There are hundreds of ethnic groups over a vast number of provinces. The diet and lifestyle of each is different based upon cultural/ethnic traditions and the environment. Several studies mentioned in this review have been done in particular areas and/or on specific population groups with regards to obesity and health risks associated with being overweight. Obesity is a multifactorial disease that is associated with genetic, physiological, environmental, and cultural/traditional perspectives in order to provide a broadened view on this epidemic in China. In this review, we will assess specific obesity gene and environment interactions, childhood obesity etiology, metabolic syndrome, and dietary and behavioral causes. We attempt to discuss obesity issues particularly in the Han Chinese population ranging from children, adolescents, adults to geriatrics.
Keywords: Obesity, overweight, China, insulin resistance, hypertension, type 2 diabetes mellitus, metabolic syndrome, dyslipidemia, etiology, ghrelin, alleles, intronic, atherosclerosis, atherogenic, amyloid, interleukin, Hyperglycemia, glutathione, thiobarbituric, procarcinogenic, malnutrition, preventable
Current Pharmaceutical Design
Title: Obesity in China: What are the Causes?
Volume: 17 Issue: 12
Author(s): Karen M. von Deneen, Qin Wei, Jie Tian and Yijun Liu
Affiliation:
Keywords: Obesity, overweight, China, insulin resistance, hypertension, type 2 diabetes mellitus, metabolic syndrome, dyslipidemia, etiology, ghrelin, alleles, intronic, atherosclerosis, atherogenic, amyloid, interleukin, Hyperglycemia, glutathione, thiobarbituric, procarcinogenic, malnutrition, preventable
Abstract: To address the causes for obesity in all of China is not feasible in a single article. There are hundreds of ethnic groups over a vast number of provinces. The diet and lifestyle of each is different based upon cultural/ethnic traditions and the environment. Several studies mentioned in this review have been done in particular areas and/or on specific population groups with regards to obesity and health risks associated with being overweight. Obesity is a multifactorial disease that is associated with genetic, physiological, environmental, and cultural/traditional perspectives in order to provide a broadened view on this epidemic in China. In this review, we will assess specific obesity gene and environment interactions, childhood obesity etiology, metabolic syndrome, and dietary and behavioral causes. We attempt to discuss obesity issues particularly in the Han Chinese population ranging from children, adolescents, adults to geriatrics.
Export Options
About this article
Cite this article as:
M. von Deneen Karen, Wei Qin, Tian Jie and Liu Yijun, Obesity in China: What are the Causes?, Current Pharmaceutical Design 2011; 17 (12) . https://dx.doi.org/10.2174/138161211795656765
DOI https://dx.doi.org/10.2174/138161211795656765 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Antioxidants and Neuroprotection in the Adult and Developing Central Nervous System
Current Medicinal Chemistry Reversing Breast Cancer Stem Cell into Breast Somatic Stem Cell
Current Pharmaceutical Biotechnology Synthetic Glucocorticoids: Antenatal Administration and Long-term Implications
Current Pharmaceutical Design Pregnancy, Physical Activity and Weight Control to Prevent Obesity and Future Chronic Disease Risk in Both Mother and Child
Current Women`s Health Reviews Prophylaxis of Venous Thromboembolism in Major Orthopedic Surgery: A Practical Approach
Cardiovascular & Hematological Agents in Medicinal Chemistry In Utero Exposure to Phthalates and Fetal Development
Current Medicinal Chemistry Identifying Novel Targets for Treatment of Liver Fibrosis: What Can We Learn from Injured Tissues which Heal Without a Scar?
Current Drug Targets Antibiotic Properties and Applications of Lactoferrin
Current Pharmaceutical Design The Association Between HIV/AIDS During Pregnancy and Fetal Growth Parameters in Florida: A Population Based Study
Current HIV Research Amphetamine-Type Medicines: A Review of Pharmacokinetics, Pharmacodynamics, and Toxicological Aspects.
Current Clinical Pharmacology Polymorphism in Endothelin-1 Gene: An Overview
Current Clinical Pharmacology Equilibrative Nucleoside Transporters in Fetal Endothelial Dysfunction in Diabetes Mellitus and Hyperglycaemia
Current Vascular Pharmacology The Disposal of Reactive Carbonyl Species through Carnosine Conjugation: What We Know Now
Current Medicinal Chemistry The Pluripotential Effects of Hypolipidemic Treatment for Polycystic Ovary Syndrome (PCOS): Dyslipidemia, Cardiovascular Risk Factors and Beyond
Current Pharmaceutical Design Nitric Oxide Synthase and Cyclooxygenase Pathways: A Complex Interplay in Cellular Signaling
Current Medicinal Chemistry Dyslipidemia and Cardiovascular Disease Prevention in South Asians: A Review and Discussion of Causes, Challenges and Management Strategies
Current Diabetes Reviews Thiazolidinediones and Type 2 Diabetes: From Cellular Targets to Cardiovascular Benefit
Current Drug Targets Etiology of the Metabolic Syndrome
Current Cardiology Reviews Plasminogen Activator Inhibitor with Very Long Half-life (VLHL PAI-1) can Reduce Bleeding in PAI-1-deficient Patients
Cardiovascular & Hematological Disorders-Drug Targets Nutritional Supplements Modulating Metabolic Syndrome Risk Factors and the Prevention of Cardiovascular Disease
Current Nutrition & Food Science